NASH Observatory

⏿ The PanNASH Initiative is an interactive web-based platform presenting global NASH statistics to inform NASH control and research.

Type 2 Diabetes, NAFLD, and cardiovascular risk

Patients with T2DM and NAFLD exhibit higher risk of CVD compared with T2DM without NAFLD. In their review, C. Caussy et al. (Hopital Lyon Sud, France) underline that several studies have provided evidence that NAFLD could be an independent cardiovascular risk factor. A potential synergistic increase of cardiovascular risk between...
Read MoreType 2 Diabetes, NAFLD, and cardiovascular risk

Hepatic fibrosis, cardiometabolic risk factors: The Framingham Heart Study

Liver stiffness, as assessed by vibration-controlled transient elastography (VCTE), correlates with hepatic fibrosis, an important predictor of liver-related and all-cause mortality. Although liver fat is associated with cardiovascular risk factors, the association between hepatic fibrosis and cardiovascular risk factors is less clear...
Read MoreHepatic fibrosis, cardiometabolic risk factors: The Framingham Heart Study

HSI screening for metabolic steatopathy in patients with T2D

The purpose of this study by H. Fennoun et al. (University Hospital, Casablanca, Morocco) was to determine the interest of hepatic steatosis index in the detection of hepatic steatosis in patients with type 2 diabetes in order to establish an appropriate screening program of this disease in the population of diabetics hospitalized in Morocco...
Read MoreHSI screening for metabolic steatopathy in patients with T2D

Liver regeneration and nanotubes: an intercellular communication

Human mesenchymal stromal cells are adult stem cells, which feature hepatotropism. They support liver regeneration through amelioration of hepatic inflammation and lipid accumulation in a mouse model of NASH. To study mesenchymal stromal cells actions on fatty liver mechanistically, MJ Hsu et al...
Read MoreLiver regeneration and nanotubes: an intercellular communication

NAFLD burden in Saudi Arabia and United Arab Emirates

Morbidity related to NAFLD and resulting NASH is likely to increase dramatically in the coming decades, especially in the Gulf countries, where there is already an epidemic of obesity and diabetes melittus. In their article, K. Alswat et al. (Liver Disease Research Center, College of Medicine, King Saud University, Riyad) estimated...
Read MoreNAFLD burden in Saudi Arabia and United Arab Emirates

Machine learning-based approach to liver histology assessment

Manual histologic assessment is currently the accepted standard for diagnosing and monitoring disease progression in nonalcoholic steatohepatitis (NASH), but is limited by variability in interpretation and insensitivity to change. A. Taylor-Weiner et al. (PathAI, Boston, Massachusetts, USA) describe here a machine learning-based approach to liver...
Read MoreMachine learning-based approach to liver histology assessment

Mechanisms, screening, prevention, and management of CVD in patients with NAFLD

Cardiovascular disease, rather than liver decompensation, remains the leading cause of morbidity and mortality in patients with NAFLD and NASH. A significant proportion of the cardiovascular risk in NASH is likely attributable to shared metabolic risk factors. Nevertheless, there is much interest in understanding the independent contribution...
Read MoreMechanisms, screening, prevention, and management of CVD in patients with NAFLD